Barclays »

Singular Genomics Systems In shares owned by Barclays

Quarter-by-quarter ownership of Singular Genomics Systems In (OMIC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.0k 409 14.67
2024-06-30 $3.0k 409 7.34

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Singular Genomics Systems In

Tang Capital Management
Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Vanguard Group
Perceptive Advisors
BlackRock
Geode Capital Management
HighTower Advisors
BlackRock
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In